Optimizing an EP reprocessing program is not a transactional, logistical task, it is a collaborative, organizational task. For a program to be successful, it must have sponsors in hospital management and include participation from both clinicians, technologists, supply chain and lab management. The reprocessing program must be tailored to the lab and its execution must be data-driven. This means the reprocessor must know about past utilization patterns, national average device prices, rejection and buy-back rates, par levels, and device configurations by case type. Data should drive the ongoing management of the specialty reprocessing program, so that managers and stakeholders at and around the EP lab constantly have visibility to the results and trends of the reprocessing program.